- Rizatriptan, a commonly used migraine medication, was evaluated for rapid relief from vertigo or dizziness during vestibular migraine attacks.
- The drug did not significantly reduce symptoms within 1 hour and showed no advantage over placebo.
- 222 adults were enrolled in the study, and it found that rizatriptan may not be effective for treating vestibular migraine attacks.
- Rizatriptan showed medium-sized effects at 24 hours in reducing motion sensitivity.
- Participants reported higher rates of minor side effects such as fatigue and drowsiness when taking rizatriptan.
- The findings suggest a need for further research into effective acute treatments for vestibular migraine.
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
